Health Sciences Pink Sheet Forward View - Simple Exponential Smoothing
Health Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of Health Sciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 1st of March 2026 the relative strength index (rsi) of Health Sciences' share price is below 20 . This usually indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Health Sciences hype-based prediction, you can estimate the value of Health Sciences Gr from the perspective of Health Sciences response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Health Sciences Gr on the next trading day is expected to be 0.00 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Health Sciences after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Health |
Health Sciences Additional Predictive Modules
Most predictive techniques to examine Health price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Health using various technical indicators. When you analyze Health charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Health Sciences Simple Exponential Smoothing Price Forecast For the 2nd of March
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Health Sciences Gr on the next trading day is expected to be 0.00 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Health Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Health Sciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Health Sciences Pink Sheet Forecast Pattern
| Backtest Health Sciences | Health Sciences Price Prediction | Research Analysis |
Health Sciences Forecasted Value
In the context of forecasting Health Sciences' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Health Sciences' downside and upside margins for the forecasting period are 0.00 and 0.00, respectively. We have considered Health Sciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Health Sciences pink sheet data series using in forecasting. Note that when a statistical model is used to represent Health Sciences pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Health Sciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Health Sciences Gr. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Health Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Health Sciences Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Health Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Health Sciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Health Sciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 1 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.00 | 0.00 | 0.00 |
|
Health Sciences Hype Timeline
Health Sciences Gr is currently traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Health is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Health Sciences is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.13. Health Sciences Gr had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 3 days. Check out Historical Fundamental Analysis of Health Sciences to cross-verify your projections.Health Sciences Related Hype Analysis
Having access to credible news sources related to Health Sciences' direct competition is more important than ever and may enhance your ability to predict Health Sciences' future price movements. Getting to know how Health Sciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Health Sciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ADXS | Ayala Pharmaceuticals | 0.00 | 0 per month | 21.95 | 0.22 | 122.19 | (53.64) | 734.55 | |
| AGTX | Agentix Corp | 0.00 | 0 per month | 3.82 | 0.05 | 5.26 | (6.67) | 49.60 | |
| GRTX | Galera Therapeutics | 0.00 | 0 per month | 4.25 | 0.18 | 21.23 | (8.70) | 35.00 | |
| IBOGF | Universal Ibogaine | 0.00 | 0 per month | 18.69 | 0.12 | 52.50 | (31.03) | 141.59 | |
| NBCO | Neon Bloom | 0.00 | 7 per month | 0.00 | 0.08 | 1.54 | 0.00 | 40.26 | |
| EVIO | EVIO Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VGLS | Vg Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STMM | Stemcell Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AAGH | America Great Health | 0.00 | 6 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IONM | Assure Holdings Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Health Sciences
For every potential investor in Health, whether a beginner or expert, Health Sciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Health Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Health. Basic forecasting techniques help filter out the noise by identifying Health Sciences' price trends.Health Sciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Health Sciences pink sheet to make a market-neutral strategy. Peer analysis of Health Sciences could also be used in its relative valuation, which is a method of valuing Health Sciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Story Coverage note for Health Sciences
The number of cover stories for Health Sciences depends on current market conditions and Health Sciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Health Sciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Health Sciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Health Pink Sheet
Health Sciences financial ratios help investors to determine whether Health Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Sciences security.